news & events

Check out what we’ve been up to and where we can connect!


FHI Clinical announces the closing of its acquisition of the clinical trials business of South Africa-based Triclinium Clinical Development (TCD)

February 8, 2022
FHI Clinical Inc. announces today the official closing of its acquisition of the clinical trials business of Triclinium Clinical Development Proprietary Limited (TCD), a full-service, South Africa-based CRO. With the acquisition, FHI Clinical expands its share of the infectious disease (ID) clinical development market and becomes the dominant service provider in sub-Saharan Africa.

Read more »


World Vaccine Congress Washington 2022

April 18-21, 2022
Attending the World Vaccine Congress 2022? Stop by our booth for a presentation about COVID-19 vaccine development, conducting trials in sub-Saharan Africa or using novel methods to ensure equitable access to clinical research. Members of our team will also be available to talk about our capabilities and services.

Read more »

2022 WAC-CREP conference

March 17-19, 2022
At the 5th annual WAC-CREP conference, FHI Clinical employees are presenting findings from research being conducted within the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) network.

Read more »